Bukhari Shazia Anwer, Ahmed Muhammad Masood, Anjum Fozia, Anwar Haseeb, Naqvi Syed Ali Raza, Zahra Tauseef, Batool Uzma
Department of Biochemistry, Government College University, Faisalabad, Pakistan.
Department of Chemistry, Government College University, Faisalabad, Pakistan.
Pak J Pharm Sci. 2018 Jul;31(4(Supplementary)):1565-1570.
Prevalence of hepatitis C virus (HCV) has been seen in more than 15% of Pakistani population. For the treatment of this infection, only two medicines, interferon, and ribavirin were approved in 1998. The concerned physicians evaluate side effects of these two antiviral drugs only during the treatment period. The long-term extra hepatic side effects are being neglected. This retrospective study was conducted with reference to induced infertility in HCV treated 40 male patients from the period 2008-2015. Possible effects of interferon therapy on fertility hormones and seminal parameters were assessed. Level of fertility hormones like serum Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH), and testosterone was measured. For seminal parameters, guidelines from World Health Organization (WHO) were followed. Among forty cases of HCV patients who received interferon, only 14 (35%) have children and 26 (65%) could not conceive (p = 0.0372). After HCV treatment, HCV positive patients showed a significant change in the level of FSH, LH (p<0.05). Especially, it decreased testosterone level (p=0.0096). Similarly, HCV treatment significantly decreased sperm count (p=0.001) and motility (p=0.0005).
在超过15%的巴基斯坦人口中发现了丙型肝炎病毒(HCV)感染。对于这种感染的治疗,1998年仅有两种药物被批准使用,即干扰素和利巴韦林。相关医生仅在治疗期间评估这两种抗病毒药物的副作用。长期的肝外副作用一直被忽视。这项回顾性研究针对2008年至2015年期间接受HCV治疗的40名男性患者的不育症进行。评估了干扰素治疗对生育激素和精液参数的可能影响。测量了血清促卵泡激素(FSH)、促黄体生成素(LH)和睾酮等生育激素水平。对于精液参数,遵循了世界卫生组织(WHO)的指南。在40例接受干扰素治疗的HCV患者中,只有14例(35%)有孩子,26例(65%)无法受孕(p = 0.0372)。HCV治疗后,HCV阳性患者的FSH、LH水平有显著变化(p<0.05)。尤其是,睾酮水平下降(p = 0.0096)。同样,HCV治疗显著降低了精子数量(p = 0.001)和活力(p = 0.0005)。